NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC Drug Patent Profile
✉ Email this page to a colleague
When do Neomycin And Polymyxin B Sulfates And Bacitracin Zinc patents expire, and what generic alternatives are available?
Neomycin And Polymyxin B Sulfates And Bacitracin Zinc is a drug marketed by Bausch And Lomb, Padagis Us, and Sciegen Pharms Inc. and is included in three NDAs.
The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?
- What are the global sales for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?
- What is Average Wholesale Price for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?
Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
What excipients (inactive ingredients) are in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC? | NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC excipients list |
DailyMed Link: | NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC at DailyMed |
Pharmacology for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
Drug Class | Aminoglycoside Antibacterial Polymyxin-class Antibacterial |
Physiological Effect | Decreased Cell Wall Synthesis & Repair |